Equity Incentive Plan (Tables)

12 Months Ended

Dec. 31, 2022

Schedule of Additional Information on Stock Option Grants And Vesting

The following table summarizes additional information on stock option grants and vesting (in thousands):

	2019 Plan
	Year Ended December 31, 2022		Year Ended December 31, 2021
Total fair value of stock options granted	$	2,898	$	2,583
Total fair value of options vested		3,306		2,911

Schedule of Black Scholes model for the Private Warrants

To estimate the fair value of the Private Warrants as of December 31, 2022 and 2021, the Company used a Black Scholes closed form model, which is a Level 3 fair value measurement. Significant inputs used in the Black Scholes model for the Private Warrants were as follows:

	December 31, 2022			December 31, 2021
Expected volatility		73.00	%		27.00	%
Expected term (in years)		1.94			2.94
Risk free interest rate		4.43	%		0.96	%
Dividend yield		0.00	%		0.00	%
Exercise Price	$	11.50		$	11.50
Fair value of Common Stock	$	2.10		$	6.80

The following table summarizes the assumptions used in the valuation models to determine the fair value of awards granted to employees and non-employees under both the 2019 Plan:

	Year Ended December 31, 2022		Year Ended December 31, 2021
Expected volatility	42.78 - 42.90%		43.22 - 44.61%
Expected term (in years)		6.0		6.0
Dividend yield	0%		0%
Risk free interest rate	1.0 - 1.62%		0.70 - 1.16%

Stock Based Compensation Expense Included In Consolidated Statements of Comprehensive Loss

Stock-based compensation expense is included in the Consolidated Statements of Comprehensive Loss within the following line items (in thousands):

	December 31,
	2022		2021
Cost of revenues	$	1,640	$	1,373
General and administrative		2,088		1,573
Research and development		584		279
Sales and marketing		824		755
Total	$	5,136	$	3,980

Restricted Stock Units [Member]

Schedule of RSUs Activity Under 2019 Plan

The following table summarizes the Company’s RSU activity for performance based RSUs awarded to employees and for time-based RSUs granted to non-employee directors under the 2019 Plan:

	RSUs
Description	Outstanding
Outstanding at December 31, 2021		1,513,892
Granted		576,889
Vested- non-employee directors awards		(106,991	)
Forfeited		(107,121	)
Expired		—
Outstanding at December 31, 2022		1,876,669

2019 Plan [Member]

Schedule of Stock Option Activity Under 2019 Plan

The following table summarizes the Company’s stock option activity under the 2019 Plan:

Description	Options Outstanding			Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (Years)		Aggregate Intrinsic Value (1)
Options outstanding, December 31, 2020		4,260,753		$	8.46		9.0
Granted		1,415,371			7.88
Exercised		(4,676	)		8.00			$	1
Forfeited		(496,842	)		8.09
Expired		(80,924	)		8.16
Options outstanding, December 31, 2021		5,093,682		$	8.34		8.4
Granted		1,135,850			6.00
Exercised		—			—			$	—
Forfeited		(273,195	)		7.51
Expired		(198,558	)		8.24
Options outstanding, December 31, 2022		5,757,779		$	7.92		7.6	$	—
Options vested and exercisable, December 31, 2022		3,836,439		$	8.36		7.1	$	—
Options vested and expected to vest, December 31, 2022		5,757,779		$	7.92		7.6	$	—

(1)Aggregate intrinsic value (in thousands) represents the difference between the estimated fair value of the underlying common stock and the exercise price of outstanding, in-the-money options.